175 related articles for article (PubMed ID: 1505775)
1. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.
Messmer E; Bornfeld N; Foerster M; Schilling H; Wessing A
Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):391-6. PubMed ID: 1505775
[TBL] [Abstract][Full Text] [Related]
2. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
Seregard S; Lundell G; Lax I; af Trampe E; Kock E
Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
4. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
[TBL] [Abstract][Full Text] [Related]
6. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
[TBL] [Abstract][Full Text] [Related]
9. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
11. Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy.
Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
Ophthalmology; 2002 Jun; 109(6):1137-41. PubMed ID: 12045056
[TBL] [Abstract][Full Text] [Related]
12. Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma.
Corrêa ZM; Augsburger JJ; Freire J; Eagle RC
Arch Ophthalmol; 1999 Feb; 117(2):259-61. PubMed ID: 10037576
[TBL] [Abstract][Full Text] [Related]
13. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
14. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
Schilling H; Sehu KW; Lee WR
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272
[TBL] [Abstract][Full Text] [Related]
15. Panophthalmitis with acute scleral necrosis after brachytherapy of a malignant melanoma of the ciliary body.
Bodanowitz S; Strempel I; Wiegand W; Kroll P
Ger J Ophthalmol; 1995 Nov; 4(6):380-2. PubMed ID: 8751105
[TBL] [Abstract][Full Text] [Related]
16. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
17. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
[TBL] [Abstract][Full Text] [Related]
18. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
Correa ZM; Huth B; Augsburger JJ
Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
[TBL] [Abstract][Full Text] [Related]
19. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
